Document is current
Any future updates will be listed below
-
Authors
Op ’t Hoog, Catharina JP
Rieborn, Amy
Moes, Dirk Jan AR
Hendrikx, Jeroen JMA
van der Heijden, Michiel S.
Franken, Mira D.
van der Hulle, Tom
van Kruchten, Michel
Willemsen, Annelieke ECAB
Koolen, Stijn LW
Boerrigter, Emmy
ter Heine, Rob
- License Information
-
More Information
Article History
Received: 27 November 2024
Accepted: 12 February 2025
First Online: 25 February 2025
Declarations
:
: RtH has received research funding from AMGEN and consulting fees from Samsung Bioepis (paid to the institute). CJPOtH, AR, SK, JH, MvK, DJM, MF, TvdH and EB declare no potential conflicts of interest. MSvdH has received institutional research funding from Bristol Myers Squibb, 4SC, Roche, Merck Sharp & Dohme, and AstraZeneca, and consulting fees from Bristol Myers Squibb, Roche, Merck Sharp & Dohme, AstraZeneca, Pfizer, Janssen, Seattle Genetics and Daiichi Sankyo.AW has received consulting fees from AstraZeneca, Pfizer, Daiichi-Sankyo and Novartis.
